Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about glucosylceramide accumulation: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Target | Relation | Type | Str |
|---|---|---|---|
| α-Synuclein Aggregation | contributes_to | phenotype | 0.88 |
| Source | Relation | Type | Str |
|---|---|---|---|
| GBA | causes | gene | 0.93 |
| Eliglustat | prevents | drug | 0.90 |
| UGCG upregulation | compensates | process | 0.70 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Glucosylceramide Accumulation from GCase Deficiency Disrupts | 0.700 | neurodegeneration | - |
| Glucosylceramide accumulation nucleates alpha-synuclein aggr | 0.525 | parkinsons | GBA-Synuclein Loop Therapeutics for PD |
Scientific analyses that reference this entity
molecular biology | 2026-04-11 | 0 hypotheses
neurodegeneration | 2026-04-01 | 8 hypotheses Top: 0.525
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.30 · 2026-04-21
closed · Rounds: 4 · Score: 0.90 · 2026-04-06
Hypotheses and analyses mentioning glucosylceramide accumulation in their description or question text
No additional research found